Jazz Pharmaceuticals (JAZZ) Q3 2023 Earnings

Nov 8Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.07
1.59
3.25
4.91

Details

Expected EPS
4.91
Actual EPS
4.84
Surprise EPS
-0.07
Surprise Percent
-1.43%

Description

⁨Jazz Pharmaceuticals⁩ (⁦JAZZ⁩) has reported earnings of ⁦4.84⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts